Qingdao NovelBeam Technology Co.,Ltd. (SHA:688677)
China · Delayed Price · Currency is CNY 122.50
+2.83 (2.36%)
May 8, 2026, 3:00 PM CST
SHA:688677 Market Cap
SHA:688677 has a market cap or net worth of 14.52 billion as of May 8, 2026. Its market cap has increased by 309.94% in one year.
Market Cap
14.52B
Enterprise Value
14.01B
Revenue
630.18M
Ranking
n/a
PE Ratio
84.51
Stock Price
122.50
Market Cap Chart
Since February 26, 2021, SHA:688677's market cap has increased from 4.89B to 14.52B, an increase of 196.83%. That is a compound annual growth rate of 23.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 14.18B | 177.27% |
| Dec 31, 2025 | 5.11B | 12.75% |
| Dec 31, 2024 | 4.54B | -29.95% |
| Dec 29, 2023 | 6.47B | -34.12% |
| Dec 30, 2022 | 9.83B | 20.09% |
| Dec 31, 2021 | 8.18B | 67.38% |
| Feb 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Winner Medical | 18.62B |
| Shenyang Xingqi Pharmaceutical | 17.18B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.59B |
| Jiangsu Hualan New Pharmaceutical Material | 14.04B |
| Autek China | 12.84B |
| Tofflon Science and Technology Group | 10.01B |
| Eyebright Medical Technology (Beijing) | 9.88B |
| Sansure Biotech | 9.88B |